Showing results (61-70 of 67) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
The Lancet. Infectious Diseases|December 3, 2014
Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trialJoost H C M Kreijtz, Marco Goeijenbier, Fleur M Moesker, et al.The Lancet. Infectious Diseases|April 24, 2020
Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trialTill Koch, Christine Dahlke, Anahita Fathi, et al.Nature Communications|July 19, 2022
Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndromeAnahita Fathi, Christine Dahlke, Verena Krähling, et al.Nature Communications|February 28, 2025
Respiratory long COVID in aged hamsters features impaired lung function post-exercise with bronchiolization and fibrosisLaura Heydemann, Małgorzata Ciurkiewicz, Theresa Störk, et al.Frontiers in Immunology|December 3, 2021
Intranasal Delivery of MVA Vector Vaccine Induces Effective Pulmonary Immunity Against SARS-CoV-2 in RodentsBerislav Bošnjak, Ivan Odak, Joana Barros-Martins, et al.Proceedings of the National Academy of Sciences of the United States of America|June 24, 2021
Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccinationAlina Tscherne, Jan Hendrik Schwarz, Cornelius Rohde, et al.The Journal of Clinical Investigation|October 27, 2022
Stabilized recombinant SARS-CoV-2 spike antigen enhances vaccine immunogenicity and protective capacityChristian Meyer Zu Natrup, Alina Tscherne, Christine Dahlke, et al.Pageof 7